The Lung Cancer Living Room™ - The Genomic Era and Targeted Cocktail Therapy - June 19, 2012
Trever Bivona, MD, PhD, engaged in both research and clinical practice
at UCSF, discusses exciting new developments in cocktail therapies for
late stage Lung Cancers. These advances bring hope home since they
reflect how HIV/AIDS has managed to shift from a once lethal disease
to a chronically managed disease. He describes how his team is finding
new genetic mutations leading to new targeted therapies that have far
fewer side effects than traditional chemo and other systemic
therapies. "We are on the verge of really curing the majority of
patients that we treat." If you're looking for hope in our fight to
beat lung cancer, you can find plenty of it here!